ReviewAvicenna journal of medical biotechnology
A Systematic Review on Green Synthesized Selenium Nanoparticles as Antioxidant and Antidiabetic Agents: Mechanistic Insights and Therapeutic Potential.
Review in Avicenna journal of medical biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology has introduced revolutionary progress in medical sciences, providing unparalleled prospects for diagnosing and treating diseases. Notably, Nanomedicine enables targeted drug delivery, maximizes therapeutic effects, limits undesirable effects, and enhances therapeutic precision, which was unattainable with conventional methods. Furthermore, integrating natural biomolecules in nanoparticle synthesis has evolved as a sustainable approach, combining ecological safety with improved biocompatibility and pharmacological performance. This review aims to systematically scrutinize the literature on the beneficial effects of green Selenium Nanoparticles (SeNPs) on antioxidant and anti-diabetic potential. For this study, the literature was meticulously searched, and data were collected from preferred sources, including PubMed, ScienceDirect, ScienceOpen, DOAJ, Google Scholar, ResearchGate, and Scilit. The literature search was restricted to English-language works published between 2014 and 2024. Data collection focused on the antioxidant and anti-diabetic properties of green-synthesized SeNPs, which were reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach. Methods like DPPH, ABTS, and FRAP assays were used to assess the antioxidant activity. This review finds that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.